Atropine Sulfate
NDC 63323-580, Atropine Sulfate, injection, solution, from Fresenius Kabi USA, LLC.
- Product NDC
- 63323-580
- Status
- Listed
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- ENDOTRACHEAL, INTRAMEDULLARY, INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA209260
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63323-580 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ATROPINE SULFATE.4 mg/mL
Pharmacologic classes
Anticholinergic [EPC]; Cholinergic Antagonists [MoA]; Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63323-580-20 | 63323058020 | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-580-20) / 20 mL in 1 VIAL, MULTI-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/310c8a74-ea24-4357-8099-81e394b1634eMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=63323-580
Use it
Look up 63323-580 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63323-580 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63323-580. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.